Showing 31 news articles about Hepatitis C treatment side-effects

Filters Content type: News Topic: Hepatitis C treatment side-effects

Older, interferon-based treatments often had difficult side-effects. Modern treatments, using direct-acting antivirals are well tolerated, with few side-effects.

Hepatitis C treatment side-effects

Why do people with HIV delay hepatitis C treatment?

News
26 July 2022
Hepatitis C treatment

Routine clinical use of DAAs highly effective and safe in people with HIV/HCV in Europe

News
19 April 2018
Side effects

Viral suppression protects against long-term liver damage caused by older HIV drugs

News
29 January 2018
Side effects

D:A:D study: long-term treatment with tenofovir associated with increased risk of serious liver disease

News
21 January 2016
Hepatitis C treatment side-effects

Abacavir/lamivudine could be driving liver damage in ART-treated patients with HIV/HCV co-infection

News
14 October 2015
Hepatitis C treatment

Sustained response to treatment reduces fatigue in hepatitis C patients

News
6 May 2014
Hepatitis C treatment

Merck combination suppresses HCV in mono-infected and co-infected patients

News
21 March 2014
Hepatitis C treatment

Faldaprevir plus interferon and ribavirin cures hepatitis C in most people with HIV/HCV co-infection

News
5 March 2014
Hepatitis C treatment

Six-week oral treatment can cure hard-to-treat hepatitis C patients

News
4 March 2014
Hepatitis C treatment

Low lymphocyte count a risk factor for infections for people taking HCV therapy

News
16 January 2014
New & experimental hepatitis C treatment

Faldaprevir demonstrates good early response in genotype 1 HIV/HCV co-infection

News
22 October 2013
New & experimental hepatitis C treatment

Simeprevir with interferon effective for HIV/HCV co-infected people with genotype 1 hepatitis C

News
21 October 2013
New & experimental hepatitis C treatment

Daclatasvir works well against hepatitis C either with interferon or in all-oral regimen

News
10 October 2013
Hepatitis C treatment

Treating HCV genotypes 2 and 3 in HIV/HCV co-infected people

News
27 September 2013
Hepatitis C treatment

HIV/HCV co-infected people can do well on hepatitis C triple therapy despite contraindications

News
22 July 2013
Hepatitis C treatment side-effects

Fear of future health problems encourage people to start and complete HCV therapy but concern about side-effects is a deterrent

News
28 June 2013
Hepatitis C treatment

Triple-drug HCV therapy comes with high risk of serious adverse events for people with cirrhosis

News
30 April 2013
Hepatitis C treatment

French studies report real-world data on use of telaprevir and boceprevir in people with HIV and hepatitis C co-infection

News
5 March 2013
Hepatitis C treatment side-effects

Small UK study suggests that depression does not have an impact on hepatitis C treatment outcomes in people co-infected with HIV

News
4 January 2013
Hepatitis C treatment

Adherence to hepatitis C treatment: unravelling the complexities

News
13 December 2012
New & experimental hepatitis C treatment

Hepatitis C patients with cirrhosis respond well to boceprevir or telaprevir with careful monitoring

News
5 December 2012
Hepatitis C treatment side-effects

Reducing ribavirin and adding EPO are both good anaemia management strategies for people taking boceprevir

News
13 November 2012
New & experimental hepatitis C treatment

Abbott interferon-free combination 'promising' in harder-to-treat patients with hepatitis C

News
12 November 2012
Hepatitis C treatment side-effects

European guidelines on management of mental health for people with hepatitis C published

News
16 October 2012